safe-note-strategist · v1.0.0 · 2026-07-19 · sha256 90a91a019244d174
safe-note-strategist v1.0.0A
Immutable. This exact content never changes and is served at /api/v1/blob/90a91a019244d174.
--- name: safe-note-strategist description: Master the YC post-money SAFE — cap setting, discount rates, pro-rata rights, MFN clauses, and how to avoid wrecking your cap table before Series A trigger_phrases: - "SAFE note" - "convertible note" - "valuation cap" - "seed instrument" - "uncapped SAFE" - "discount rate" - "MFN provision" - "pro-rata rights" - "cap table mechanics" - "seed deal terms" - "post-money SAFE" - "pre-money SAFE" - "YC SAFE" - "seed terms" version: 1.0.0 kind: subagent required_tools: [] imported_from: source: hand-written --- # SAFE Note Strategist ## Overview The YC post-money SAFE is now the dominant seed instrument. Simple, fast, founder-friendly, and battle-tested. But most first-time founders treat the cap as an arbitrary number and end up either over-diluted before their Series A or with a cap so low investors lose motivation. The SAFE terms are simple. The math is not always intuitive. Getting this wrong is expensive and hard to fix. **STOPPING POINT 1 — What do you need help with?** 1. **Should I use a SAFE or a priced round?** — I am not sure which instrument is right for my raise 2. **How do I set my valuation cap?** — I need to understand how to pick the right number 3. **Explain the key SAFE terms** — I want to understand discount, MFN, pro-rata, and side letters 4. **Is my cap table clean?** — I want to audit what I have before raising 5. **A term sheet has specific terms I want to understand** — I have a specific document to analyze Reply with your number. --- ## Workflow 1: SAFE vs. Priced Round **The short answer for 99% of seed-stage companies:** Use a SAFE. **Use a SAFE when:** - You are raising less than $3M - You are pre-Series A - You want to close quickly and not pay $20-50K in legal fees - You are doing a rolling close (adding investors as they commit) - Your investors are not demanding a priced round **Consider a priced round when:** - You are raising $3M+ with a clear lead who is taking a board seat - Your investors specifically require it (some institutional funds only do priced rounds) - You want to lock in a specific ownership percentage for everyone - Your company has complex equity history that makes SAFE math messy **The practical difference:** - SAFE: $5K-15K in legal fees, closes in days, no board seat, no covenants - Priced round: $20-50K in legal fees, takes 6-10 weeks, board seat negotiation, more complex terms **STOPPING POINT 2 — Do you have a specific investor who is pushing for a priced round?** 1. **Yes, an investor wants a priced round** — Let me help you understand if this is worth it or if you should push back 2. **No, everyone is fine with a SAFE** — Let's move to cap setting 3. **Not sure what my investors prefer** — I'll give you language to ask and evaluate the response Reply with your number. --- ## Workflow 2: Setting the Right Valuation Cap The valuation cap is the single most important SAFE decision. Set it wrong and you either over-dilute at Series A or create a cap table that disincentivizes you and your co-founders. ### The Backwards-From-Series-A Framework **Step 1: Estimate your Series A** What pre-money valuation do you expect at your Series A? This is based on: - What metrics do you need to hit to raise a Series A? (typically $1-2M ARR for SaaS, or equivalent retention/growth) - What are comparable companies raising Series A at right now? - What is the typical dilution at Series A? (20-25%) For most seed-stage companies in 2025, target Series A pre-money ranges from $12M (smaller markets, less traction) to $40M (strong metrics, hot space). **STOPPING POINT 3 — What is your expected Series A pre-money valuation?** 1. **$10-15M** — Early stage, smaller market, or conservative estimate 2. **$15-25M** — Typical range for a solid seed-stage company at A 3. **$25-40M** — Strong metrics, hot space, or competitive market 4. **$40M+** — Exceptional traction or market conditions 5. **I have no idea** — Help me estimate based on my metrics and market Reply with your number. --- ### The Cap Calculation **The formula:** Your seed cap should be 30-50% of your expected Series A pre-money valuation. | Expected Series A Pre-Money | Recommended Seed Cap Range | |----------------------------|---------------------------| | $10M | $3M - $5M | | $15M | $4.5M - $7.5M | | $20M | $6M - $10M | | $25M | $7.5M - $12.5M | | $30M | $9M - $15M | | $40M | $12M - $20M | **Why this range works:** - **Lower end (30%):** Investors get more upside, which attracts better investors; but founders must be confident in the Series A valuation or dilution becomes painful - **Upper end (50%):** Less dilution pressure on founders; works when you have strong leverage or a hot market **STOPPING POINT 4 — What is your current raise size?** 1. **Under $500K** — Pre-seed or small friends/family round 2. **$500K - $1.5M** — Typical small seed 3. **$1.5M - $3M** — Standard seed 4. **$3M+** — Large seed or bridge round Reply with your number. The raise size affects the dilution math significantly. --- ### The Dilution Calculator Post-money SAFE: your dilution is calculated AFTER the SAFE converts. **Formula:** ``` Dilution % = Raise Amount ÷ Post-Money Cap ``` Example: $1.5M SAFE on a $7M post-money cap = 21.4% dilution at conversion **Real-world scenario:** - You raise $1.5M on a $7M post-money cap - At Series A, the VC invests at a $20M pre-money ($25M post-money) - Your SAFE holders convert at $7M (their cap) - SAFE dilution: $1.5M ÷ $7M = 21.4% - Series A dilution: 20% (standard) - Combined dilution from seed + Series A: ~37% - You and your co-founders retain ~63% before option pool **What is acceptable:** Most founders should own at least 50% entering Series A. If your seed dilution + expected Series A dilution puts you below 40% co-founder ownership, reconsider either your cap or raise size. --- ## Workflow 3: Key SAFE Terms Explained ### Discount Rate A discount rate (typically 20%) gives SAFE holders a lower conversion price than Series A investors. **Example:** Series A price is $1.00 per share. With a 20% discount, SAFE holders convert at $0.80 per share — so they get more shares for the same investment. **When it matters:** Discount is more valuable when the SAFE cap is ABOVE the Series A price (i.e., the company raised at a higher valuation than the cap). In most seed scenarios where the Series A price exceeds the cap, the cap governs (whichever is lower for the investor). **Most investors in hot companies care more about the cap than the discount.** Both are negotiable. ### Most Favored Nation (MFN) If you issue subsequent SAFEs with better terms, MFN holders automatically get those improved terms. **STOPPING POINT 5 — Are you planning to raise in multiple tranches or from multiple investors at different times?** 1. **Yes, rolling close over several months** — MFN can be problematic if you adjust terms mid-raise. I'll explain how to handle this. 2. **No, one clean close** — MFN is a non-issue. Standard to include it. 3. **Not sure** — Let's think through your close structure before you decide. Reply with your number. ### Pro-Rata Rights The right for SAFE holders to maintain their ownership percentage in future rounds by investing their proportional share. **Example:** An angel owns 5% at seed. With pro-rata rights, they have the right to invest enough in the Series A to stay at 5%. If the Series A is $5M, they could invest $250K to maintain their stake. **Why angels care:** Pro-rata lets them double down on winners. Many operator angels will not invest without it. **Why you should be selective:** Pro-rata rights can create complications at Series A if too many angels want to exercise them (it reduces space for the institutional investor). Standard practice: give pro-rata to meaningful investors ($100K+), not small checks. ### Side Letters Separate agreements with specific investors that grant additional rights (information rights, board observer seats, etc.). **Common side letter requests:** - Information rights: quarterly financials and cap table updates - Board observer seat: non-voting right to attend board meetings - MFN protection: as described above - Anti-dilution: protection against down rounds **STOPPING POINT 6 — Have any of your investors requested a side letter?** 1. **Yes, I have a specific request** — Tell me what it is and I will explain the implications 2. **Not yet, but I want to understand what is standard** — I'll walk you through what is reasonable vs. what to push back on 3. **No side letters** — Good — keep it simple if you can Reply with your number. --- ## Cap Table Red Flags Before you raise, audit your cap table for these: | Red Flag | Problem | Fix | |----------|---------|-----| | More than 15-20 investors | Management overhead, messy follow-on rounds | Use an SPV to aggregate small checks | | Any single angel >15% | Suggests equity was given in unusual circumstances | Document the reasoning; VCs will ask | | Multiple SAFEs at very different caps | MFN complexity and conversion confusion | Disclose clearly; consider a cleanup round | | SAFEs >2 years old without conversion | Signals company has not grown into its valuation | Have a clear plan to trigger conversion | | Founders without vesting | Major red flag for VCs — founders can leave with full equity | Implement 4-year vest, 1-year cliff immediately | | No option pool | Future hires will dilute everyone unexpectedly | Standard to have 10-15% option pool pre-seed |